Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 182, Issue -, Pages 66-76
Publisher
Elsevier BV
Online
2023-01-13
DOI
10.1016/j.ejca.2022.12.028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
- (2021) Daniela E. Oprea-Lager et al. Frontiers in Oncology
- Clear cell renal cell carcinoma bone metastasis: What should be considered in prognostic evaluation
- (2019) Zixiong Huang et al. EJSO
- Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study
- (2018) Aline Guillot et al. Clinical Genitourinary Cancer
- Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre
- (2018) F. Ruatta et al. EUROPEAN JOURNAL OF CANCER
- CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
- (2017) Bernard Escudier et al. EUROPEAN UROLOGY
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
- (2017) Kenji Omae et al. Oncotarget
- Improving detection of bone metastases in renal cell carcinoma
- (2015) Lisa Hutchinson Nature Reviews Clinical Oncology
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma
- (2014) Rana R. McKay et al. EUROPEAN UROLOGY
- Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor
- (2014) Paolo Grassi et al. Future Oncology
- The Health Care Burden of Skeletal Related Events in Patients with Renal Cell Carcinoma and Bone Metastasis
- (2014) Carina Antczak et al. JOURNAL OF UROLOGY
- Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
- (2013) R J Motzer et al. BRITISH JOURNAL OF CANCER
- Zoledronic acid in lung cancer with bone metastases: a review
- (2013) Dolores Isla et al. Expert Review of Anticancer Therapy
- Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey
- (2013) Daniele Santini et al. PLoS One
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
- (2011) M. Bianchi et al. ANNALS OF ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib
- (2010) B. Beuselinck et al. ANNALS OF ONCOLOGY
- Skeletal complications and survival in renal cancer patients with bone metastases
- (2010) Emma Woodward et al. BONE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search